It was popular for a while to refer to the cannabis space as another dot-com bubble. There were definitely similarities: a new industry full of potential was getting investors exciting, driving up share prices until the bubble burst. Post-legalization, many of the great green hopes touted by early cannabis bulls were up in smoke, to use a tired idiom. But…
Read More
The COVID-19 crisis has been difficult, to say the least. Millions are out of work as the economy prepares to contract sharply. And while stock markets have rebounded, many individual stocks are still in the dumps. As economies reopen, there are two growth companies at the top of my buy list. These businesses were crushed when the economy shuttered, yet…
Read More
Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is a Canadian icon. Last year, it generated more than $10 billion in sales. But there’s a problem: growth has stagnated. Last quarter, revenue declined by 8.7% year over year. “After a corporate restructuring in the fourth quarter of 2019 and a bevy of new products hitting the market in the New Year, Molson Coors…
Read More
Uncertain times often lead to surprising success stories. The COVID-19 pandemic crushed entire industries, while pushing cannabis ever closer to full legitimacy. Marijuana businesses depend on innovation – something that is critical in the current environment. As COVID-19 rages, rapid-fire local legislation often disrupts traditional supply lines. Given the patchwork of laws and questionable legality in many jurisdictions, marijuana companies…
Read More
Cronos Group (TSX:CRON)(NASDAQ:CRON) finally reported its delayed fourth0quarter and full-year 2019 results on March 30. Much to investors’ disappointment, the company’s quarterly revenue growth in Canada was negative and massive inventory charges drowned spirits. There’s one more piece of information that could warrant a downward revision to the marijuana firm’s potential revenue growth rate. For a start, this was the…
Read More
Cannabis sales have seen significant growth recently as consumers around the country continue to stockpile supplies to prepare for prolonged self-isolation. This phenomenon isn’t new, of course. Historically, as the economy starts to go down, consumers tend to rely more on vices such as alcohol or, in this case, weed. As dispensaries in many areas are being considered essential businesses,…
Read More
Every pot stock has been crushed. The marijuana bear market of 2019 sent cannabis ETFs down by more than 50%. The coronavirus bear market of 2020 has compounded the damage. Pot demand continues to grow. That’s not the issue. In 2019, the problem was commoditization. Tilray sent the industry into a nosedive last summer when it reported a pricing collapse.…
Read More
Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canada Goose Holdings (TSX:GOOS)(NYSE:GOOS) are two popular Canadian stocks. The two stocks have recently hit new 52-week lows. Buying a stock that’s hit a 52-week low and that rebounds after is a profitable strategy. But there is a risk that the stock might go down further. It’s therefore important to look at a company’s outlook to…
Read More
Canopy Growth (TSX:WEED)(NYSE:CGC) stock soared over 15% on Friday after the cannabis firm released a strong earnings report that revealed a 62% sequential net revenue growth to $124 million for its fiscal Q3 2019 ended in December 2019. Such high double-digit growth rates, especially on a sequential quarter-over-quarter basis, deserve a huge celebration and should naturally drive the stock price…
Read More
TFSAs are perfect vehicles for saving. All of your capital will grow tax free, and when it’s time for withdrawals, those are tax free, too. What kind of stocks should you be holding in a TFSA? There are several viable options. The biggest mistake is simply to hold cash. Mediocre returns essentially nullify your tax benefits. If you want to…
Read More